Johnson & Johnson Innovation – JJDC — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.
AI & Machine LearningDigital HealthHealthtechBaltimore, US
Ryan Sysko(Executive Officer, Director)Suzanne Clough(Executive Officer)Kevin McRaith(President and CEO)Anand Iyer(Chief AI Officer)Chris Bergstrom(Executive Officer)Anand K. Iyer(Executive Officer)
Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCExcel Venture ManagementTCP Venture Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.